Continued cemiplimab with addition of chemotherapy beyond progression in patients with advanced NSCLC on 1L cemiplimab monotherapy: 5-year outcomes of EMPOWER-Lung 1


Garassino M. C., Baramidze A., Kilickap S., Sezer A., ÖZGÜROĞLU M., Gumus M., ...More

JOURNAL OF THORACIC ONCOLOGY, vol.20, no.3, 2025 (SCI-Expanded, Scopus) identifier

  • Publication Type: Article / Abstract
  • Volume: 20 Issue: 3
  • Publication Date: 2025
  • Journal Name: JOURNAL OF THORACIC ONCOLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CINAHL, MEDLINE
  • Istanbul University-Cerrahpasa Affiliated: No